Contineum Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Contineum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Contineum Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Contineum Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $805k | 69k | 11.75 |
| 2025-06-30 | $30k | 7.7k | 3.97 |
| 2025-03-31 | $93k | 13k | 6.98 |
| 2024-12-31 | $365k | 25k | 14.65 |
| 2024-09-30 | $51k | 2.7k | 19.14 |
| 2024-06-30 | $37k | 2.1k | 17.61 |